Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Re: Hutchinson M, Fox RJ, Havrdova E, et al. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison. Curr Med
[MRI and CSF features in neuromyelitis optica].
Quantified CSF antibody reactivity against myelin in multiple sclerosis.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Gait variability in people with neurological disorders: A systematic review and meta-analysis.
Early and Extensive Spinal White Matter Involvement in Neuromyelitis Optica.
Unkind cytokines: current evidence for the potential role of cytokines in immune-mediated depression.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression.
Clinical Guidance of Community Physiotherapists Regarding People with MS: Professional Development and Continuity of Care.
Exercising away the blues: can it help multiple sclerosis-related depression?
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): a single case report follow-up study.
Fiber-Optic Bronchoscopy and Volume-Cycled Mouthpiece Ventilation for a Patient with Multiple Sclerosis and Ventilatory Failure.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
Endocannabinoid signalling and the deteriorating brain.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
Genomic medicine and risk prediction across the disease spectrum.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
Relapsing remitting multiple sclerosis in x-linked charcot-marie-tooth disease with central nervous system involvement.
Pages
« first
‹ previous
…
591
592
593
594
595
596
597
598
599
…
next ›
last »